Alkeon Capital Management
AKRO

Alkeon Capital Management’s Akero Therapeutics AKRO Stock Holding History

Alkeon Capital Management’s Portfolio AKRO Stock Details AKRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-1,850,934
Closed -$87.9M – 113
2025
Q3 		$87.9M Hold
1,850,934
– – 0.13% 68
2025
Q2 		$98.8M Buy
1,850,934
+300,000
+19% +$13.6M 0.16% 61
2025
Q1 		$62.8M Sell
1,550,934
-210,334
-12% -$8.92M 0.13% 66
2024
Q4 		$49M Sell
1,761,268
-1,563,736
-47% -$47.4M 0.1% 72
2024
Q3 		$95.4M Sell
3,325,004
-2,216
-0.1% -$57.8K 0.16% 61
2024
Q2 		$78.1M Hold
3,327,220
– – 0.13% 71
2024
Q1 		$84M Sell
3,327,220
-437,000
-12% -$10.5M 0.14% 70
2023
Q4 		$87.9M Sell
3,764,220
-3,160
-0.1% -$62.3K 0.2% 58
2023
Q3 		$191M Buy
3,767,380
+300,000
+9% +$14M 0.34% 40
2023
Q2 		$162M Buy
3,467,380
+246,650
+8% +$11.3M 0.28% 49
2023
Q1 		$123M Sell
3,220,730
-23,185
-0.7% -$1.03M 0.27% 62
2022
Q4 		$178M Buy
3,243,915
+81,656
+3% +$3.5M 0.69% 45
2022
Q3 		$108M Buy
3,162,259
+542,588
+21% +$8.3M 0.35% 65
2022
Q2 		$24.8M Buy
2,619,671
+200,000
+8% +$2.09M 0.07% 113
2022
Q1 		$34.3M Sell
2,419,671
-60,000
-2% -$1.05M 0.07% 116
2021
Q4 		$52.4M Hold
2,479,671
– – 0.1% 108
2021
Q3 		$55.4M Sell
2,479,671
-10,023
-0.4% -$227K 0.09% 110
2021
Q2 		$61.8M Sell
2,489,694
-6,077
-0.2% -$171K 0.09% 113
2021
Q1 		$72.4M Buy
2,495,771
+208,141
+9% +$6.3M 0.11% 108
2020
Q4 		$59M Buy
2,287,630
+6,923
+0.3% +$193K 0.1% 111
2020
Q3 		$70.2M Buy
2,280,707
+1,282,333
+128% +$44.8M 0.13% 93
2020
Q2 		$24.9M Buy
998,374
+73,780
+8% +$1.69M 0.06% 114
2020
Q1 		$19.6M Buy
924,594
+485,000
+110% +$10.4M 0.08% 109
2019
Q4 		$9.76M Sell
439,594
-63,128
-13% -$1.31M 0.04% 108
2019
Q3 		$11.4M Buy
502,722
+281,722
+127% +$6.56M 0.04% 116
2019
Q2 		$4.23M Buy
+221,000
New +$4.19M 0.02% 129

Other funds holding AKRO

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Alkeon Capital Management's AKRO Position: Q4 2025 in Review

Alkeon Capital Management sold out of Akero Therapeutics (AKRO) in Q4 2025, closing a stake of 1,850,934 shares — an estimated $87.9M sold.

Alkeon Capital Management first reported a position in AKRO in Q2 2019 and held it in 26 quarters. The position peaked at $191M in Q3 2023. 2 funds tracked by Wall St. Rank hold AKRO as of Q4 2025.

  • Alkeon Capital Management reported no remaining Akero Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Alkeon Capital Management sold 1,850,934 Akero Therapeutics shares in Q4 2025, an estimated $87.9M.
  • Alkeon Capital Management first reported a position in Akero Therapeutics in Q2 2019 and held it in 26 quarters.
  • Alkeon Capital Management's Akero Therapeutics position peaked at $191M in Q3 2023.
  • 2 funds tracked by Wall St. Rank held Akero Therapeutics as of Q4 2025.

Based on Alkeon Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.